BRIDGEWAY CAPITAL MANAGEMENT, LLC
Position in LRMR — Larimar Therapeutics, Inc.
CIK 1107261
HOUSTON, TX
Position in LRMR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$185,472
-$238,260 QoQ
Shares Held
41,216
-62.9% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $59,315,164 across 112 Biotechnology names. LRMR ranks #78 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLUE |
Monte Rosa Therapeutics, Inc.
|
528,698 | $8,697,082 | |
| 2 | PBYI |
Puma Biotechnology, Inc.
|
775,341 | $4,954,428 | |
| 3 | EXEL |
Exelixis, Inc.
|
66,100 | $2,835,029 | |
| 4 | KROS |
Keros Therapeutics, Inc.
|
195,017 | $2,152,987 | |
| 5 | SGMT |
Sagimet Biosciences Inc.
|
299,641 | $1,565,624 | |
| 6 | BDTX |
Black Diamond Therapeutics, Inc.
|
723,477 | $1,541,006 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
22,000 | $1,498,860 | |
| 8 | KYTX |
Kyverna Therapeutics, Inc.
|
149,900 | $1,293,637 |
All Filings in LRMR
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $185,472 | 41,216 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $423,732 | 111,216 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $252,637 | 78,216 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $298,294 | 103,216 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $221,914 | 103,216 | Shares | Sole | 2025-05-15 | |
| 2024-03-31 | $641,355 | 84,500 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $543,725 | 119,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $445,560 | 112,800 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $431,314 | 137,800 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $624,234 | 137,800 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $259,364 | 62,800 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $389,116 | 121,599 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $238,334 | 121,599 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $254,340 | 62,800 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $677,612 | 62,800 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $292,200 | 20,000 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $155,492 | 10,250 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||